Evidence map›Paper›PMID 29529050›Full record

ArticlePloS one2018

Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.

Ana Valero-Jiménez, Joaquín Zúñiga, José Cisneros, Carina Becerril, Alfonso Salgado, Marco Checa, Ivette Buendía-Roldán, Criselda Mendoza-Milla, Miguel Gaxiola, Annie Pardo and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ana Valero-JiménezInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Joaquín ZúñigaInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
José CisnerosInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Carina BecerrilInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Alfonso SalgadoInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Marco ChecaInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Ivette Buendía-RoldánInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Criselda Mendoza-MillaInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Miguel GaxiolaInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.
Annie PardoFacultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad de México, México.
Moisés SelmanInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Ciudad de México, México.ORCID 0000-0002-1022-4783
Instituto Nacional de Enfermedades Respiratorias · MXUniversidad Nacional Autónoma de México · MX

Funding

UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
NIH HHS U42 OD012210
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by epithelial cell activation, expansion of the fibroblast population and excessive extracellular matrix accumulation. The mechanisms are incompletely understood but evidence indicates that the deregulation of several proteases contributes to its pathogenesis. Transmembrane protease serine 4 (TMPRSS4) is a novel type II transmembrane serine protease that may promote migration and facilitate epithelial to mesenchymal transition (EMT), two critical processes in the pathogenesis of IPF. Thus, we hypothesized that over-expression of TMPRSS4 in the lung could promote the initiation and/or progression of IPF. In this study we first evaluated the expression and localization of TMPRSS4 in IPF lungs by real time PCR, western blot and immunohistochemistry. Then we examined the lung fibrotic response in wild-type and TMPRSS4 deficient mice using the bleomycin-induced lung injury model. We found that this protease is upregulated in IPF lungs, where was primarily expressed by epithelial and mast cells. Paralleling the findings in vivo, TMPRSS4 was expressed by alveolar and bronchial epithelial cells in vitro and unexpectedly, provoked an increase of E-cadherin. No expression was observed in normal human or IPF lung fibroblasts. The lung fibrotic response evaluated at 28 days after bleomycin injury was markedly attenuated in the haplodeficient and deficient TMPRSS4 mice. By morphology, a significant reduction of the fibrotic index was observed in KO and heterozygous mice which was confirmed by measurement of collagen content (hydroxyproline: WT: 164±21.1 μg/lung versus TMPRSS4 haploinsufficient: 110.2±14.3 μg/lung and TMPRSS4 deficient mice: 114.1±24.2 μg/lung (p<0.01). As in IPF, TMPRSS4 was also expressed in epithelial and mast cells. These findings indicate that TMPRSS4 is upregulated in IPF lungs and that may have a profibrotic role.

Indexed as

Up-RegulationAnimalsBleomycinCell LineEpithelial-Mesenchymal TransitionFibrosisHumansIdiopathic Pulmonary FibrosisLungLung InjuryMembrane ProteinsMice, Inbred C57BLMice, KnockoutSerine EndopeptidasesBleomycinMembrane ProteinsSerine EndopeptidasesTMPRSS4 protein, humanTmprss4 protein, mouse

Identifiers

PMID29529050
PMCPMC5846721
OpenAlexW2794379741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.